These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 24389129)

  • 1. Angiotensin 1-7 ameliorates diabetic cardiomyopathy and diastolic dysfunction in db/db mice by reducing lipotoxicity and inflammation.
    Mori J; Patel VB; Abo Alrob O; Basu R; Altamimi T; Desaulniers J; Wagg CS; Kassiri Z; Lopaschuk GD; Oudit GY
    Circ Heart Fail; 2014 Mar; 7(2):327-39. PubMed ID: 24389129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin 1-7 mediates renoprotection against diabetic nephropathy by reducing oxidative stress, inflammation, and lipotoxicity.
    Mori J; Patel VB; Ramprasath T; Alrob OA; DesAulniers J; Scholey JW; Lopaschuk GD; Oudit GY
    Am J Physiol Renal Physiol; 2014 Apr; 306(8):F812-21. PubMed ID: 24553436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of angiotensin-(1-7) with perindopril is better than single therapy in ameliorating diabetic cardiomyopathy.
    Hao P; Yang J; Liu Y; Zhang M; Zhang K; Gao F; Chen Y; Zhang C; Zhang Y
    Sci Rep; 2015 Mar; 5():8794. PubMed ID: 25740572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azilsartan ameliorates diabetic cardiomyopathy in young db/db mice through the modulation of ACE-2/ANG 1-7/Mas receptor cascade.
    Sukumaran V; Tsuchimochi H; Tatsumi E; Shirai M; Pearson JT
    Biochem Pharmacol; 2017 Nov; 144():90-99. PubMed ID: 28789938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.
    Basu R; Oudit GY; Wang X; Zhang L; Ussher JR; Lopaschuk GD; Kassiri Z
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2096-108. PubMed ID: 19801494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-(1-7) treatment mitigates right ventricular fibrosis as a distinctive feature of diabetic cardiomyopathy.
    Hao PP; Yang JM; Zhang MX; Zhang K; Chen YG; Zhang C; Zhang Y
    Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1007-19. PubMed ID: 25724492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin IV attenuates diabetic cardiomyopathy
    Zhang M; Sui W; Xing Y; Cheng J; Cheng C; Xue F; Zhang J; Wang X; Zhang C; Hao P; Zhang Y
    Theranostics; 2021; 11(18):8624-8639. PubMed ID: 34522203
    [No Abstract]   [Full Text] [Related]  

  • 8. Rutin alleviates diabetic cardiomyopathy and improves cardiac function in diabetic ApoEknockout mice.
    Huang R; Shi Z; Chen L; Zhang Y; Li J; An Y
    Eur J Pharmacol; 2017 Nov; 814():151-160. PubMed ID: 28826911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of Angiotensin (1-7)-Mediated Signaling Preserves Endothelial Function Through Reducing Oxidative Stress in Diabetes.
    Zhang Y; Liu J; Luo JY; Tian XY; Cheang WS; Xu J; Lau CW; Wang L; Wong WT; Wong CM; Lan HY; Yao X; Raizada MK; Huang Y
    Antioxid Redox Signal; 2015 Oct; 23(11):880-92. PubMed ID: 25867182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver X receptor agonist treatment attenuates cardiac dysfunction in type 2 diabetic db/db mice.
    He Q; Pu J; Yuan A; Yao T; Ying X; Zhao Y; Xu L; Tong H; He B
    Cardiovasc Diabetol; 2014 Nov; 13():149. PubMed ID: 25416469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of adipose triglyceride lipase in the heart aggravates diabetic cardiomyopathy in db/db mice.
    Inoue T; Kobayashi K; Inoguchi T; Sonoda N; Maeda Y; Hirata E; Fujimura Y; Miura D; Hirano K; Takayanagi R
    Biochem Biophys Res Commun; 2013 Aug; 438(1):224-9. PubMed ID: 23886955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing cardiac steatosis and oxidative stress in type 2 diabetes.
    Monji A; Mitsui T; Bando YK; Aoyama M; Shigeta T; Murohara T
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H295-304. PubMed ID: 23709595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivo.
    Cao N; Wong YG; Rosli S; Kiriazis H; Huynh K; Qin C; Du XJ; Kemp-Harper BK; Ritchie RH
    Circ Heart Fail; 2015 May; 8(3):572-81. PubMed ID: 25737497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with angiotensin-(1-9) alleviates the cardiomyopathy in streptozotocin-induced diabetic rats.
    Zheng H; Pu SY; Fan XF; Li XS; Zhang Y; Yuan J; Zhang YF; Yang JL
    Biochem Pharmacol; 2015 May; 95(1):38-45. PubMed ID: 25801006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist-induced hypertrophy and diastolic dysfunction are associated with selective reduction in glucose oxidation: a metabolic contribution to heart failure with normal ejection fraction.
    Mori J; Basu R; McLean BA; Das SK; Zhang L; Patel VB; Wagg CS; Kassiri Z; Lopaschuk GD; Oudit GY
    Circ Heart Fail; 2012 Jul; 5(4):493-503. PubMed ID: 22705769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin.
    Dai B; Li H; Fan J; Zhao Y; Yin Z; Nie X; Wang DW; Chen C
    Cardiovasc Diabetol; 2018 Sep; 17(1):123. PubMed ID: 30180843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme-2 overexpression improves left ventricular remodeling and function in a rat model of diabetic cardiomyopathy.
    Dong B; Yu QT; Dai HY; Gao YY; Zhou ZL; Zhang L; Jiang H; Gao F; Li SY; Zhang YH; Bian HJ; Liu CX; Wang N; Xu H; Pan CM; Song HD; Zhang C; Zhang Y
    J Am Coll Cardiol; 2012 Feb; 59(8):739-47. PubMed ID: 22340266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-(1-7) prevents systemic hypertension, attenuates oxidative stress and tubulointerstitial fibrosis, and normalizes renal angiotensin-converting enzyme 2 and Mas receptor expression in diabetic mice.
    Shi Y; Lo CS; Padda R; Abdo S; Chenier I; Filep JG; Ingelfinger JR; Zhang SL; Chan JS
    Clin Sci (Lond); 2015 May; 128(10):649-63. PubMed ID: 25495544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy.
    Arow M; Waldman M; Yadin D; Nudelman V; Shainberg A; Abraham NG; Freimark D; Kornowski R; Aravot D; Hochhauser E; Arad M
    Cardiovasc Diabetol; 2020 Jan; 19(1):7. PubMed ID: 31924211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene Therapy With Angiotensin-(1-9) Preserves Left Ventricular Systolic Function After Myocardial Infarction.
    Fattah C; Nather K; McCarroll CS; Hortigon-Vinagre MP; Zamora V; Flores-Munoz M; McArthur L; Zentilin L; Giacca M; Touyz RM; Smith GL; Loughrey CM; Nicklin SA
    J Am Coll Cardiol; 2016 Dec; 68(24):2652-2666. PubMed ID: 27978950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.